C
China NT Pharma Group Company Ltd
HKEX:1011
China NT Pharma Group Company Ltd
HKEX:1011
Price:
0.79
HKD
8.22%
Market Closed
Market Cap:
HK$532.7m
Relative Value
The Relative Value of one China NT Pharma Group Company Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.79 HKD, China NT Pharma Group Company Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China NT Pharma Group Company Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
China NT Pharma Group Company Ltd Competitors
China NT Pharma Group Company Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China NT Pharma Group Company Ltd
HKEX:1011
|
532.7m HKD | 25.4 | -6.7 | -18.6 | -18.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
989.2B USD | 15.1 | 47.8 | 32.2 | 34.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573.4B USD | 6.1 | 21.5 | 15 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.1B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.9B USD | 4.7 | 16.6 | 10.4 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
230.9B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.1B GBP | 5.2 | 32.1 | 15.3 | 22.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.2 | 12.7 | 9.3 | 11 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.3B USD | 2.6 | 20.8 | 7.3 | 9.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
